GT Biopharma, Inc. (GTBP)
0.76
-0.05
(-6.62%)
USD |
NASDAQ |
Dec 31, 10:39
GT Biopharma Market Cap: 8.083M for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 81.01B |
| SELLAS Life Sciences Group, Inc. | 501.40M |
| Lyell Immunopharma, Inc. | 465.57M |
| Plus Therapeutics, Inc. | 73.85M |
| Geron Corp. | 852.20M |
Market Cap Related Metrics
| Price to Book Value | 2.695 |
| Price | 0.76 |
| Earnings Yield | -446.7% |